General MedicationsTOPICALStandard
DESONIDE
DESONIDE
Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DESONIDE is listed in Drugs@FDA under application 213632 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DESONIDE Form and strength LOTION;TOPICAL - 0.05% Sponsor ALEMBIC Submission history Latest submission status date: 2020-08-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview DESONIDE is listed in Drugs@FDA under application 213632 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DESONIDE Form and strength LOTION;TOPICAL - 0.05% Sponsor ALEMBIC Submission history Latest submission status date: 2020-08-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.